CTOs on the Move

SpineGuard

www.spineguard.com

 
Founded in 2009 in France and the USA by Pierre Jerome and Stephane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 80,000 surgical procedures worldwide. Sixteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.spineguard.com
  • 1434 Spruce Street Suite 100
    Boulder, CO USA 80302
  • Phone: 720.726.8085

Executives

Name Title Contact Details

Similar Companies

R and M Distributing

R and M Distributing is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sanuwave

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.

Idex Health and Science

Idex Health and Science is a Oak Harbor, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Qosina Corporation

Qosina Corporation is a Edgewood, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valeritas

Valeritas is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas` portfolio is headlined by the V-Go® disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy.